Selected ticker: GSK.US | View: Annual | Period: 2025-12-31
Line Item
Step Type
Value
Revenue
adjust
$32.67B
Cost of Goods Sold
adjust
$-9.02B
Gross Profit
subtotal
$23.65B
SG&A
adjust
$-9.09B
R&D
adjust
$-7.53B
Operating Income
subtotal
$8.34B
Other / Non-Operating Items
adjust
$-2.62B
Net Income
subtotal
$5.72B